UBS Group’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.7K Buy
+15,631
New +$29.7K ﹤0.01% 6863
2024
Q4
Sell
-142,747
Closed -$271K 8760
2024
Q3
$271K Sell
142,747
-24,876
-15% -$47.3K ﹤0.01% 4486
2024
Q2
$308K Buy
167,623
+17,754
+12% +$32.7K ﹤0.01% 4278
2024
Q1
$250K Buy
+149,869
New +$250K ﹤0.01% 4562
2023
Q4
Sell
-614
Closed -$445 8197
2023
Q3
$445 Sell
614
-450
-42% -$326 ﹤0.01% 7342
2023
Q2
$897 Sell
1,064
-8,676
-89% -$7.31K ﹤0.01% 6986
2023
Q1
$11.3K Sell
9,740
-648
-6% -$752 ﹤0.01% 6426
2022
Q4
$7.58K Buy
10,388
+8,634
+492% +$6.3K ﹤0.01% 7691
2022
Q3
$2K Sell
1,754
-5,650
-76% -$6.44K ﹤0.01% 8606
2022
Q2
$10K Buy
7,404
+2,744
+59% +$3.71K ﹤0.01% 6915
2022
Q1
$13K Buy
+4,660
New +$13K ﹤0.01% 6993
2021
Q4
Sell
-565
Closed -$3K 9171
2021
Q3
$3K Sell
565
-457
-45% -$2.43K ﹤0.01% 7651
2021
Q2
$6K Sell
1,022
-592
-37% -$3.48K ﹤0.01% 7329
2021
Q1
$6K Buy
1,614
+1,144
+243% +$4.25K ﹤0.01% 7191
2020
Q4
$1K Sell
470
-7,368
-94% -$15.7K ﹤0.01% 7177
2020
Q3
$10K Sell
7,838
-2,544
-25% -$3.25K ﹤0.01% 5964
2020
Q2
$19K Buy
+10,382
New +$19K ﹤0.01% 5739
2020
Q1
Sell
-620
Closed -$1K 7048
2019
Q4
$1K Buy
620
+155
+33% +$250 ﹤0.01% 6853
2019
Q3
$1K Sell
465
-222
-32% -$477 ﹤0.01% 6856
2019
Q2
$2K Sell
687
-450
-40% -$1.31K ﹤0.01% 6733
2019
Q1
$5K Buy
+1,137
New +$5K ﹤0.01% 6319
2018
Q4
Sell
-365
Closed -$2K 7100
2018
Q3
$2K Sell
365
-1,074
-75% -$5.89K ﹤0.01% 6802
2018
Q2
$9K Buy
+1,439
New +$9K ﹤0.01% 6262